1 September 2020
Angelfish Investments Plc
("Angelfish" or "the Company")
Results of Meetings
The Company announces that at the General Meeting held at 11.00am today, all resolutions were duly passed.
Consequently, the Company will continue to support its existing investments, focused on the service and technology sectors (including products related to social or life enhancement), with a view to achieving exits where opportunities arise and will narrow the focus of its investment strategy going forward, to target businesses and companies where the opportunity exists to develop complementary services that support the NHS in delivering high quality, patient focused, integrated care. It is intended that the Company will, principally, invest through secured convertible loan notes or acquire controlling shareholdings in UK based or overseas companies whose managements are proposing to seek a stock market quotation in the short or medium term, although the acquisition of minority interests in companies already admitted to the AIM market of the or the AQSE Growth Market of the Aquis Stock Exchange will not necessarily be precluded. The Directors will also consider investment opportunities where the natural exit strategy will be through a trade sale.
The Company further announces that at the Separate Class Meeting of the Preference Shareholders held at 11.05am today, no proxies were received and no Preference Shareholders attended and the meeting was therefore not quorate. Accordingly, the directors of the Company adjourned the meeting and it will be reconvened at Kings Court, Railway Street, Altrincham, Cheshire WA14 2RD at 10.00am on 15 September 2020. Preference Shareholders are invited to submit their proxies using the original form of proxy, which remains valid for the reconvened meeting, by 10.00 a.m. on 11 September 2020. Pursuant to Regulation 41 of the Uncertificated Securities Regulations 2001, only those members registered in the register of members of the Company as at 10.00 a.m. on 11 September 2020 shall be entitled to attend and vote at this meeting in respect of the number of shares registered in their name at that time.
As a result of the Separate Class Meeting of the Preference Shareholders being adjourned, the proposed conversion of 7.1% Cumulative Redeemable Preference Shares 2021, the proposed subdivision of the ordinary shares of 0.01p each, and the proposed subscription of £20,000 by Brian Jones will not complete today.
This announcement contains information which, prior to its disclosure, was inside information for the purposes of Article 7 of EU Regulation 596/2014.
The Directors of the Company take responsibility for this announcement.
Angelfish Investments Plc +44 (0)7772 013116
Richard Walker, Director
Novum Securities Limited +44 (0)207 399 9400
AQSE Corporate Adviser
David Coffman / Daphne Zhang
About Angelfish Investments Plc
The Company's Ordinary Shares and Preference Shares are admitted to trading on the AQSE Growth Market in London. The Company has the trading symbol ANGP for its Ordinary Shares and the trading symbol ANGS for its Preference Shares.
This information is provided by RNS, the news service of the
. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom
. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact email@example.com
or visit www.rns.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the